Aliases & Classifications for Hydrarthrosis

MalaCards integrated aliases for Hydrarthrosis:

Name: Hydrarthrosis 12 44 15 73

Classifications:



External Ids:

Disease Ontology 12 DOID:528
ICD9CM 35 719.08
MeSH 44 D006833

Summaries for Hydrarthrosis

MalaCards based summary : Hydrarthrosis is related to synovitis and osteoarthritis, and has symptoms including arthralgia, edema and painful swollen joints. An important gene associated with Hydrarthrosis is MEFV (MEFV, Pyrin Innate Immunity Regulator), and among its related pathways/superpathways are Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds and Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways. The drugs Prednisolone phosphate and Methylprednisolone have been mentioned in the context of this disorder. Affiliated tissues include bone, lung and brain, and related phenotypes are homeostasis/metabolism and skeleton

Related Diseases for Hydrarthrosis

Diseases related to Hydrarthrosis via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 43)
# Related Disease Score Top Affiliating Genes
1 synovitis 30.1 IL1B IL1RN MMP13 MMP3
2 osteoarthritis 29.6 ADAMTS5 IL1B MMP13 MMP3
3 arthritis 29.4 ADAMTS5 IL1B IL1RN MMP13 MMP3
4 intermittent hydrarthrosis 12.6
5 systemic onset juvenile idiopathic arthritis 10.2 IL1RN MEFV
6 juvenile ankylosing spondylitis 10.2 IL1RN MEFV
7 familial cold autoinflammatory syndrome 1 10.2 IL1B MEFV
8 cervical adenitis 10.1 IL1B MEFV
9 dysferlinopathy 10.1 AQP1 MIP
10 diabetes insipidus, nephrogenic, autosomal 10.1 AQP1 AQP3 MIP
11 rheumatoid lung disease 10.1 IL1B MMP3
12 impaired renal function disease 10.1 AQP1 AQP3
13 periostitis 10.1 IL1RN SLCO2A1
14 peritonitis 10.1 AQP1 IL1B MEFV
15 vulvar vestibulitis syndrome 10.1 IL1B IL1RN
16 brain edema 10.1 AQP1 IL1B MIP
17 gastric cancer, hereditary diffuse 10.1 IL1B IL1RN
18 schnitzler syndrome 10.1 IL1B IL1RN
19 cinca syndrome 10.1 IL1B IL1RN MEFV
20 adult-onset still's disease 10.1 IL1B IL1RN MEFV
21 aphthous stomatitis 10.1 IL1B IL1RN MEFV
22 meniere disease 10.1 AQP1 AQP3 AQP7 MIP
23 pericarditis 10.1 IL1B IL1RN MEFV
24 familial mediterranean fever 10.1 IL1B IL1RN MEFV
25 osteosclerotic myeloma 10.1 IL1B IL1RN
26 joint disorders 10.0 IL1B IL1RN MMP3
27 hypersensitivity vasculitis 10.0 C4A MEFV PRTN3
28 corneal ulcer 10.0 IL1B MMP3
29 multicentric reticulohistiocytosis 10.0
30 familial calcium pyrophosphate deposition 10.0
31 bone deterioration disease 10.0 IL1B MMP13 MMP3
32 palindromic rheumatism 10.0 IL1B MEFV PRTN3
33 periodontal disease 10.0 IL1B IL1RN MMP3
34 frozen shoulder 10.0 ASIC2 ASIC3 IL1B MMP3
35 aortic aneurysm, familial abdominal, 1 10.0 IL1B MMP13 MMP3
36 immune system disease 10.0 IL1B MEFV PRTN3
37 meningococcemia 10.0 IL1B IL1RN
38 pericardium disease 10.0 IL1RN MEFV
39 behcet syndrome 9.9 C4A IL1B IL1RN MEFV
40 glomerulonephritis 9.9 C4A IL1B PRTN3
41 bone structure disease 9.7 ADAMTS5 IL1B MMP13 MMP3
42 rheumatoid arthritis 9.7 IL1B IL1RN MMP13 MMP3 PRTN3
43 bone inflammation disease 9.4 ADAMTS5 IL1B IL1RN MMP13 MMP3 PRTN3

Graphical network of the top 20 diseases related to Hydrarthrosis:



Diseases related to Hydrarthrosis

Symptoms & Phenotypes for Hydrarthrosis

UMLS symptoms related to Hydrarthrosis:


arthralgia, edema, painful swollen joints, metatarsalgia, other symptoms referable to joint, stiffness of joint, not elsewhere classified in icd10cm, effusion of joint, other specified sites

MGI Mouse Phenotypes related to Hydrarthrosis:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 homeostasis/metabolism MP:0005376 9.7 AQP1 AQP3 AQP7 AQP9 ASIC3 IL1B
2 skeleton MP:0005390 9.23 ADAMTS5 AQP1 AQP3 IL1B IL1RN MEFV

Drugs & Therapeutics for Hydrarthrosis

Drugs for Hydrarthrosis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 103)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Prednisolone phosphate Approved, Vet_approved Phase 4 302-25-0
2
Methylprednisolone Approved, Vet_approved Phase 4 83-43-2 6741
3
Prednisolone Approved, Vet_approved Phase 4 50-24-8 5755
4
Methylprednisolone hemisuccinate Approved Phase 4 2921-57-5
5
Infliximab Approved Phase 4 170277-31-3
6
Glucosamine Approved, Investigational Phase 4 3416-24-8 439213
7
Celecoxib Approved, Investigational Phase 4 169590-42-5 2662
8
Liraglutide Approved Phase 4 204656-20-2 44147092
9
Prednisolone hemisuccinate Experimental Phase 4 2920-86-7
10 Peripheral Nervous System Agents Phase 4
11 Antiemetics Phase 4
12 Gastrointestinal Agents Phase 4,Phase 3
13 Dermatologic Agents Phase 4,Phase 3,Phase 2,Phase 1
14 glucocorticoids Phase 4
15 Hormone Antagonists Phase 4
16 Prednisolone acetate Phase 4
17 Antirheumatic Agents Phase 4,Phase 3,Phase 2,Phase 1
18 Neuroprotective Agents Phase 4
19 Autonomic Agents Phase 4
20 Protective Agents Phase 4,Phase 1,Not Applicable
21 Hormones Phase 4
22 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4
23 Antineoplastic Agents, Hormonal Phase 4
24 Anti-Inflammatory Agents Phase 4,Phase 3
25 Methylprednisolone acetate Phase 4
26 Cyclooxygenase Inhibitors Phase 4
27 Analgesics, Non-Narcotic Phase 4
28
Chondroitin Phase 4 9007-27-6 53477707
29 Cyclooxygenase 2 Inhibitors Phase 4
30 Anti-Inflammatory Agents, Non-Steroidal Phase 4
31 Analgesics Phase 4
32 Incretins Phase 4
33 Hypoglycemic Agents Phase 4
34
leucovorin Approved Phase 3,Phase 2,Phase 1 58-05-9 6006 143
35
Methotrexate Approved Phase 3,Phase 2,Phase 1 59-05-2, 1959-05-2 126941
36
Abatacept Approved Phase 3 332348-12-6 10237
37
Aluminum hydroxide Approved, Investigational Phase 3 21645-51-2
38
Formaldehyde Approved, Vet_approved Phase 3 50-00-0 712
39
Adalimumab Approved Phase 3 331731-18-1 16219006
40
Folic Acid Approved, Nutraceutical, Vet_approved Phase 3,Phase 2,Phase 1 59-30-3 6037
41
Ergocalciferol Approved, Nutraceutical Phase 3 50-14-6 5280793
42
Vitamin D3 Approved, Nutraceutical Phase 3 67-97-0 5280795 6221
43
Vitamin D Approved, Nutraceutical, Vet_approved Phase 3 1406-16-2
44 Antimetabolites, Antineoplastic Phase 3,Phase 2,Phase 1
45 Immunologic Factors Phase 3,Phase 2,Phase 1,Not Applicable
46 Pharmaceutical Solutions Phase 3,Phase 2
47 Nucleic Acid Synthesis Inhibitors Phase 3,Phase 2,Phase 1
48 Vitamin B Complex Phase 3,Phase 2,Phase 1
49 Vitamin B9 Phase 3,Phase 2,Phase 1
50 Immunosuppressive Agents Phase 3,Phase 2,Phase 1

Interventional clinical trials:

(show all 44)
# Name Status NCT ID Phase Drugs
1 Treatment Of Knee Osteoarthritis With Intra-Articular Infliximab Completed NCT01144143 Phase 4 Infliximab;Placebo;Standard of Care: Methylprednisolone acetate
2 Study on Efficacy and Safety of Chondroitin Sulfate + Glucosamine Hydrochloride Versus Celecoxib in Knee Osteoarthritis Completed NCT01425853 Phase 4 Chondroitin/Glucosamine (Droglican);Celecoxib
3 Ultrasound of the Knee in Obese Patients With Knee Osteoarthritis; Weight Maintenance Active, not recruiting NCT02931383 Phase 4 Liraglutide 3 mg (Saxenda);Liraglutide 3 mg placebo
4 A Rheumatoid Arthritis Study to Assess Early Response to Abatacept+MTX as Defined by Improvement of Synovitis Measures by Power Doppler Ultrasonography Completed NCT00767325 Phase 3 Abatacept;Methotrexate
5 Ross River Virus (RRV) Vaccine Study Completed NCT01242670 Phase 3
6 VItamin D Effect on Osteoarthritis Study Completed NCT01176344 Phase 3 Vitamin D;Placebo
7 Long-term Safety and Tolerability Study of Adalimumab in Subjects With Crohn's Disease Completed NCT00195715 Phase 3
8 Ultrasound as Imaging Biomarker of Early Response to Tocilizumab and Methotrexate in Very Early Rheumatoid Arthritis Recruiting NCT02837146 Phase 3 Methotrexate (MTX)
9 Somatosensory Stimulation in Knee Osteoarthritis Unknown status NCT02854176 Phase 2
10 Study to Evaluate the Efficacy and Safety of Intra-articular DA-5202 in Patients With Osteoarthritis of the Knee Unknown status NCT02554240 Phase 2 DA-5202 20mg;DA-5202 10mg;Na Hyaluronate 20mg
11 Effectiveness and Safety of Autologous ADRC for Treatment of Degenerative Damage of Knee Articular Cartilage Completed NCT02219113 Phase 1, Phase 2
12 Effects of Ultrasound Therapy on Cartilage Healing in Patients With Knee Osteoarthritis Completed NCT00931749 Phase 2
13 Based on the Ultrasound Evaluating the Effect of Xiaozhong Fang Particles for Knee Osteoarthritic With Synovial Fluid Recruiting NCT03586700 Phase 2 Xiao zhong fang granules;Placebo Xiao zhong fang granules
14 Treatment of Refractory Hemochromatosis Rheumatism by Anakinra: a Preliminary Phase II Study Recruiting NCT02263638 Phase 2 Anakinra
15 Effectiveness and Safety of Autologous ADRC for Treatment of Anterior Cruciate Ligament Partial Rupture Enrolling by invitation NCT02469792 Phase 1, Phase 2
16 Autologous Stromal Vascular Fraction of Cells for Treatment of Knee Articular Cartilage Dystrophy Enrolling by invitation NCT02827851 Phase 2
17 Safety and Efficacy of MK-8457 and Methotrexate (MTX) in Participants With Active Rheumatoid Arthritis Despite MTX Therapy (P08683, MK-8457-008) Terminated NCT01569152 Phase 2 MK-8457 100 mg;Dose-Matched Placebo;Methotrexate
18 Zoledronic Acid and Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma Completed NCT00742924 Phase 1 cisplatin;dexrazoxane hydrochloride;doxorubicin hydrochloride;etoposide;ifosfamide;leucovorin calcium;methotrexate;zoledronic acid;Mesna
19 Magnetic Resonance (MR) Spectroscopy In Familial Mediterranean Fever (FMF) Patients Unknown status NCT00658060
20 Determination of Adipocytokine in Synovial Fluid of Osteoarthritis Patients Unknown status NCT01993342
21 Use of Infrared Spectroscopy in Septic Arthritis Diagnosis Completed NCT02860871
22 The Effects of Joint Effusion on Proprioception Completed NCT01060215 Not Applicable
23 Effects of Joint Effusion on Quadriceps Muscle Completed NCT01314820 Not Applicable
24 MRI and Ultrasound Findings in Patients With Gout and Normal Plain Radiographs Completed NCT00584311 Not Applicable
25 Ultrasonography Assessment of Septic Arthritis on Native Joint Completed NCT02018952 Not Applicable
26 Association Between Clinical Signs and MRI Findings of the Lumbar Facet Joints Completed NCT01628939
27 Chikungunya Arthritis in the Americas Completed NCT02463968
28 Joint Ultrasound Evaluation of Asymptomatic Rheumatic Feet Completed NCT01677416
29 Early Surgery Versus Conservative Therapy for Meniscal Injuries in Older Patients Completed NCT01850719 Not Applicable
30 Time Difference Between Onsets of Lateral And Medial Hamstring Muscles During Gait in Patients With Patellofemoral Pain. Completed NCT03392688 Not Applicable
31 An Observational Study on RoActemra/Actemra (Tocilizumab) in Clinical Practice in Patients With Rheumatoid Arthritis (TRUST) Completed NCT01394276
32 Effect of Yogurts Supplemented With Mobilee on Joint Function in Healthy Individuals With Joint Discomfort Completed NCT01303432 Not Applicable
33 Efficacy of OSTENIL PLUS (Hyaluronic Acid) Versus SYNVISC-ONE in Patients With Tibiofemoral Osteoarthritis Completed NCT03203408 Not Applicable
34 Ultrasound Guided Versus Landmark Guided Small & Medium Joint Arthrocentesis Recruiting NCT03327584 Not Applicable
35 Pilot Trial to Assess the Feasibility of Implementing Objective Parameters in Patients Affected by Knee Osteoarthritis Recruiting NCT03421054 Not Applicable
36 Ultrasonography in Hemophilic Joint Disease and Serum Markers Recruiting NCT02634918
37 Ultrasound of the Knee in Obese Patients With Knee Osteoarthritis; Weight Loss Active, not recruiting NCT02931370
38 Clinical and Radiological Manifestations of Coxitis in Patients With Ankylosing Spondylitis Treated With Golimumab Active, not recruiting NCT03557853 Golimumab Injection
39 Outcome Study of Highly-cross Linked Polyethylene vs. Standard Polyethylene for Primary Posterior Stabilized (PS) Total Knee Enrolling by invitation NCT02178020
40 Walking Gait Biomechanics Following Knee Joint Effusion Not yet recruiting NCT03805464 Not Applicable
41 Methotrexate in the Treatment of Advanced Knee Osteoarthritis With Effusion-synovitis Not yet recruiting NCT03815448 Not Applicable Methotrexate
42 INDividualised EXercise for Kneecap Dislocations Not yet recruiting NCT03798483 Not Applicable
43 Efficacy and Safety of b-2Cool on Adults With Joint Discomfort Withdrawn NCT02843620 Not Applicable
44 Effect of Whole Body Vibration Therapy in Children With Juvenile Idiopathic Arthritis Withdrawn NCT00836394 Not Applicable

Search NIH Clinical Center for Hydrarthrosis

Cochrane evidence based reviews: hydrarthrosis

Genetic Tests for Hydrarthrosis

Anatomical Context for Hydrarthrosis

MalaCards organs/tissues related to Hydrarthrosis:

41
Bone, Lung, Brain, Lymph Node

Publications for Hydrarthrosis

Articles related to Hydrarthrosis:

(show all 38)
# Title Authors Year
1
Boiogito, a Kampo medicine, improves hydrarthrosis in a rat model of knee osteoarthritis. ( 26703073 )
2015
2
Successful Treatment of Intermittent Hydrarthrosis With Hydroxychloroquine. ( 26587859 )
2015
3
Pathological findings from synovium of early osteoarthritic knee joints with persistent hydrarthrosis. ( 24837400 )
2014
4
Anakinra for a refractory case of intermittent hydrarthrosis with a TRAPS-related gene mutation. ( 22887853 )
2013
5
May some cases of intermittent hydrarthrosis represent an atypical form of calcium pyrophosphate dihydrate crystal deposition disease? Usefulness of mutational analysis of the MEFV gene. ( 17889261 )
2008
6
Association of intermittent hydrarthrosis with MEFV gene mutations. ( 16802374 )
2006
7
Successful therapy with low-dose colchicine in intermittent hydrarthrosis. ( 12595650 )
2003
8
Multicentric reticulohistiocytosis with hydrarthrosis in both knee joints: disease stabilization with synovectomy, and medication with a steroid and low-dose methotrexate. ( 24383904 )
2002
9
Comparison between clinical evaluation and ultrasonography in detecting hydrarthrosis of the knee. ( 10606382 )
1999
10
Analysis of synovial fluid components of hydrarthrosis in long-term hemodialysis patients. ( 10370156 )
1999
11
Intermittent hydrarthrosis. ( 11273267 )
1998
12
Hydrarthrosis of the knee or ankle revealing metaphyseal stress fractures of the tibia. A report of 3 cases. ( 8523370 )
1995
13
Hyaluronan, cartilage destruction and hydrarthrosis in traumatic arthritis. ( 11548232 )
1994
14
The treatment of idiopathic and secondary hydrarthrosis of the knee by intra-articular Rifamycin SV. ( 2098221 )
1990
15
Participation of synovial mast cells in intermittent hydrarthrosis. ( 2467680 )
1989
16
Treatment of hydrarthrosis of the knee with manual manipulation and herbs. ( 3246884 )
1988
17
Calcium pyrophosphate crystals in intermittent hydrarthrosis. ( 3029370 )
1986
18
LE cells in intermittent hydrarthrosis. ( 6157396 )
1980
19
Periodic synoviosis (intermittent hydrarthrosis) with observations and studies on a patient. ( 4464498 )
1974
20
Tarsal hydrarthrosis in the horse: response to intra-articular injection of synthetic steroids. ( 5815590 )
1969
21
Evaluation of intra-articular injection of synthetic steroids in tarsal hydrarthrosis in cattle. ( 5691642 )
1968
22
Tarsal hydrarthrosis (bog spavin) in the horse: blood, serum, and synovial fluid findings. ( 5688981 )
1968
23
Therapeutic management of tarsal hydrarthrosis (bog spavin) in the horse by intra-articular injection of prednisolone. ( 6068578 )
1967
24
Characteristics of blood, serum, and synovial effusions in cattle with tarsal hydrarthrosis. ( 6069486 )
1967
25
Intra-articular injection of 6 alpha-methyl, 17 alpha-hydroxyprogesterone acetate in tarsal hydrarthrosis (bog spavin) in the horse. ( 5624181 )
1967
26
Acute Cervical Hydrarthrosis. ( 19790510 )
1964
27
SYPHILITIC HYDRARTHROSIS. ( 14075738 )
1963
28
Intermittent hydrarthrosis; periodic benign synovitis. ( 13567199 )
1958
29
Intermittent hydrarthrosis. ( 13383213 )
1957
30
Periodic benign synovitis; idiopathic intermittent hydrarthrosis. ( 13367081 )
1956
31
Hodgkin's disease presenting as hydrarthrosis of knee. ( 14378634 )
1955
32
Intermittent hydrarthrosis. ( 14372871 )
1955
33
Intermittent hydrarthrosis. ( 14933539 )
1952
34
Intermittent hydrarthrosis; two cases. ( 15390577 )
1949
35
The roentgenographic appearance of temporomandibular hydrarthrosis. ( 21018447 )
1946
36
Idiopathic Hydrarthrosis. ( 19988486 )
1932
37
Intermittent Hydrarthrosis: (Hydrops Intermittens Articulorum). ( 21433466 )
1930
38
Chronic Hydrarthrosis. ( 19976537 )
1913

Variations for Hydrarthrosis

Expression for Hydrarthrosis

Search GEO for disease gene expression data for Hydrarthrosis.

Pathways for Hydrarthrosis

Pathways related to Hydrarthrosis according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1
Show member pathways
12.69 AQP1 AQP3 AQP7 AQP9 ASIC2 ASIC3
2 11.71 C4A IL1B IL1RN
3
Show member pathways
11.53 ADAMTS5 IL1B MMP3
4
Show member pathways
11.44 AQP1 AQP3 AQP7 AQP9 MIP
5 11.18 IL1B IL1RN MMP3

GO Terms for Hydrarthrosis

Cellular components related to Hydrarthrosis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 plasma membrane GO:0005886 9.9 AQP1 AQP3 AQP7 AQP9 ASIC2 ASIC3
2 extracellular space GO:0005615 9.8 ADAMTS5 C4A IL1B IL1RN MMP13 MMP3
3 integral component of plasma membrane GO:0005887 9.5 AQP1 AQP7 AQP9 ASIC2 ASIC3 MIP
4 basolateral plasma membrane GO:0016323 8.92 AQP1 AQP3 AQP9 ENSG00000250424

Biological processes related to Hydrarthrosis according to GeneCards Suite gene sharing:

(show all 19)
# Name GO ID Score Top Affiliating Genes
1 proteolysis GO:0006508 9.97 ADAMTS5 C4A MMP13 MMP3 PRTN3
2 inflammatory response GO:0006954 9.88 C4A IL1B IL1RN MEFV
3 cytokine-mediated signaling pathway GO:0019221 9.85 IL1B IL1RN MMP3 PRTN3
4 transmembrane transport GO:0055085 9.7 AQP1 AQP3 AQP7 AQP9 ENSG00000250424 MIP
5 extracellular matrix disassembly GO:0022617 9.67 ADAMTS5 MMP13 MMP3
6 cation transmembrane transport GO:0098655 9.58 AQP1 ASIC2 ASIC3
7 response to vitamin D GO:0033280 9.57 AQP3 IL1B
8 cellular response to nitric oxide GO:0071732 9.56 AQP1 MMP3
9 response to acidic pH GO:0010447 9.54 ASIC2 ASIC3
10 collagen catabolic process GO:0030574 9.54 MMP13 MMP3 PRTN3
11 ammonium transmembrane transport GO:0072488 9.52 AQP1 ENSG00000250424
12 negative regulation of glutamate secretion GO:0014050 9.51 IL1B IL1RN
13 excretion GO:0007588 9.5 AQP3 AQP7 AQP9
14 sensory perception of sour taste GO:0050915 9.48 ASIC2 ASIC3
15 chronic inflammatory response to antigenic stimulus GO:0002439 9.46 IL1B IL1RN
16 detection of mechanical stimulus involved in sensory perception GO:0050974 9.43 ASIC2 ASIC3
17 carbon dioxide transmembrane transport GO:0035378 9.26 AQP1 ENSG00000250424
18 glycerol transport GO:0015793 9.26 AQP1 AQP3 AQP7 AQP9
19 water transport GO:0006833 9.02 AQP1 AQP3 AQP7 AQP9 MIP

Molecular functions related to Hydrarthrosis according to GeneCards Suite gene sharing:

(show all 12)
# Name GO ID Score Top Affiliating Genes
1 serine-type endopeptidase activity GO:0004252 9.76 C4A MMP13 MMP3 PRTN3
2 metalloendopeptidase activity GO:0004222 9.67 ADAMTS5 MMP13 MMP3
3 cation channel activity GO:0005261 9.51 ASIC2 ASIC3
4 interleukin-1 receptor binding GO:0005149 9.48 IL1B IL1RN
5 ligand-gated sodium channel activity GO:0015280 9.43 ASIC2 ASIC3
6 ammonium transmembrane transporter activity GO:0008519 9.4 AQP1 ENSG00000250424
7 water transmembrane transporter activity GO:0005372 9.37 AQP1 AQP9
8 water channel activity GO:0015250 9.35 AQP1 AQP3 AQP7 AQP9 MIP
9 glycerol channel activity GO:0015254 9.33 AQP3 AQP7 AQP9
10 acid-sensing ion channel activity GO:0044736 9.32 ASIC2 ASIC3
11 carbon dioxide transmembrane transporter activity GO:0035379 9.26 AQP1 ENSG00000250424
12 channel activity GO:0015267 9.1 AQP1 AQP3 AQP7 AQP9 ENSG00000250424 MIP

Sources for Hydrarthrosis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....